The role of uric acid as an endogenous danger signal in immunity and inflammation

Current Rheumatology Reports

Volumn 13, Issue 2, 2011, Pages 160-166

  Ghaemi Oskouie, Faranak ^a   Shi, Yan ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Adjuvanticity; IL 1 ; Inflammation; Lipids; Monosodium urate; NLRP3; TLR; Uric acid

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1BETA; LIPID; TOLL LIKE RECEPTOR; URATE; URIC ACID;

ACID PRECIPITATION; ANTIGEN PRESENTING CELL; ANTIGENICITY; ARTICLE; CHEMICAL BINDING; COMPLEMENT SYSTEM; CRYSTALLIZATION; CYTOKINE PRODUCTION; GOUT; HUMAN; HYPERURICEMIA; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; NONHUMAN; PHAGOCYTOSIS; RISK FACTOR;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNITY; CARRIER PROTEINS; CRYSTALLIZATION; DISEASE MODELS, ANIMAL; GOUT; HUMANS; INFLAMMASOMES; INFLAMMATION; MICE; URIC ACID;

EID: 79957526145     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0162-1     Document Type: Article

References (44)

1. JP Dunn GW Brooks J Mausner GP Rodnan S Cobb 1963 Social class gradient of serum uric acid levels in males JAMA 185 431 436 1:CAS:528:DyaF3sXkslOitbs%3D
2. R Terkeltaub 2010 Update on gout: new therapeutic strategies and options Nat Rev Rheumatol 6 30 38 20046204 10.1038/nrrheum.2009.236 1:CAS:528: DC%2BC3cXotlSi This is a comprehensive and contemporary review of gout.
3. Smyth CJ, Holers VM. Gout, Hyperuricemia, and Other Crystal-Associated Arthropathies. New York: Marcel Dekker, 1998.
4. A Enomoto, et al. 2002 Molecular identification of a renal urate anion exchanger that regulates blood urate levels Nature 417 447 452 12024214 1:CAS:528:DC%2BD38XjvVersrs%3D (Pubitemid 34563537)
5. DC Hooper, et al. 1998 Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis Proc Natl Acad Sci U S A 95 675 680 9435251 10.1073/pnas.95.2.675 1:CAS:528: DyaK1cXmtFaisA%3D%3D (Pubitemid 28083802)
6. RCS Seet, et al. 2010 Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study Atherosclerosis 209 215 219 19758590 10.1016/j.atherosclerosis.2009.08.012 1:CAS:528:DC%2BC3cXis1ensr4%3D
7. S Watanabe, et al. 2002 Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity Hypertension 40 355 360 12215479 10.1161/01.HYP.0000028589.66335.AA 1:CAS:528:DC%2BD38XntVKrsL0%3D (Pubitemid 35006723)
8. JA Sofaer AE Emery 1981 Genes for super-intelligence? J Med Genet 18 410 413 7334499 10.1136/jmg.18.6.410 1:STN:280:DyaL387ksFCguw%3D%3D (Pubitemid 12197058)
9. U Kanevets K Sharma K Dresser Y Shi 2009 A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity J Immunol 182 1912 1918 19201844 10.4049/jimmunol.0803777 1:CAS:528:DC%2BD1MXhsFKktbo%3D
10. Y Shi JE Evans KL Rock 2003 Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 516 521 14520412 10.1038/nature01991 1:CAS:528:DC%2BD3sXnslSis7g%3D (Pubitemid 37237047)
11. TH Steele 1999 Hyperuricemic nephropathies Nephron 81 Suppl 1 45 49 9873214 10.1159/000046298 1:CAS:528:DyaK1MXjt1GgsQ%3D%3D (Pubitemid 29015467)
12. V Vitart, et al. 2008 SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout Nat Genet 40 437 442 18327257 10.1038/ng.106 1:CAS:528:DC%2BD1cXjslCgtLc%3D (Pubitemid 351450879)
13. N Schlesinger JM Norquist DJ Watson 2009 Serum urate during acute gout J Rheumatol 36 1287 1289 19369457 10.3899/jrheum.080938 1:CAS:528: DC%2BD1MXotlSjtLs%3D
14. RW Fiddis N Vlachos PD Calvert 1983 Studies of urate crystallisation in relation to gout Ann Rheum Dis 42 Suppl 1 12 15 6615025 10.1136/ard.42.Suppl-1. 12 1:CAS:528:DyaL3sXltlOkt7k%3D (Pubitemid 13037066)
15. H Iwata S Nishio M Yokoyama A Matsumoto M Takeuchi 1989 Solubility of uric acid and supersaturation of monosodium urate: why is uric acid so highly soluble in urine? J Urol 142 1095 1098 2795738 1:STN:280:DyaK3c%2Fht1eqtw%3D%3D (Pubitemid 19250778)
16. I Kippen JR Klinenberg A Weinberger WR Wilcox 1974 Factors affecting urate solubility in vitro Ann Rheum Dis 33 313 317 4413418 10.1136/ard.33.4.313 1:CAS:528:DyaE2MXhsVKkuw%3D%3D
17. HK Tak SM Cooper WR Wilcox 1980 Studies on the nucleation of monosodium urate at 37 degrees c Arthritis Rheum 23 574 580 7378087 10.1002/art.1780230509 1:CAS:528:DyaL3cXkt1erur4%3D (Pubitemid 10101763)
18. M Kam D Perl-Treves D Caspi L Addadi 1992 Antibodies against crystals FASEB J 6 2608 2613 1592211 1:CAS:528:DyaK38XktVGkt70%3D
19. M Kam D Perl-Treves R Sfez L Addadi 1994 Specificity in the recognition of crystals by antibodies J Mol Recognit 7 257 264 7734151 10.1002/jmr.300070404 1:CAS:528:DyaK2MXjtlCgsb4%3D
20. RC Landis DO Haskard 2001 Pathogenesis of crystal-induced inflammation Curr Rheumatol Rep 3 36 41 11177769 10.1007/s11926-001-0049-7 1:STN:280:DC%2BD38%2Fgs1yksQ%3D%3D
21. M Nagase DG Baker HR Schumacher Jr 1989 Immunoglobulin G coating on crystals and ceramics enhances polymorphonuclear cell superoxide production: correlation with immunoglobulin G adsorbed J Rheumatol 16 971 976 2549242 1:CAS:528:DyaL1MXlsVSntr0%3D (Pubitemid 19220213)
22. E Ortiz-Bravo MS Sieck HR Schumacher Jr 1993 Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model Arthritis Rheum 36 1274 1285 8216421 10.1002/art.1780360912 1:CAS:528:DyaK2cXitFCns7w%3D (Pubitemid 23303118)
23. F Kozin DJ McCarty 1980 Molecular orientation of immunoglobulin G adsorbed to microcrystalline monosodium urate monohydrate J Lab Clin Med 95 49 58 7350240 1:CAS:528:DyaL3cXpt1Gquw%3D%3D (Pubitemid 10208071)
24. F Barabe C Gilbert N Liao SG Bourgoin PH Naccache 1998 Crystal-induced neutrophil activation VI. Involvment of FcgammaRIIIB (CD16) and CD11b in response to inflammatory microcrystals FASEB J 12 209 220 9472986 1:CAS:528:DyaK1cXhtVSqs78%3D (Pubitemid 28080191)
25. P Desaulniers M Fernandes C Gilbert SG Bourgoin PH Naccache 2001 Crystal-induced neutrophil activation. VII. Involvement of Syk in the responses to monosodium urate crystals J Leukoc Biol 70 659 668 11590204 1:CAS:528:DC%2BD3MXnsFOnsr8%3D (Pubitemid 32954778)
26. R Terkeltaub AJ Tenner F Kozin MH Ginsberg 1983 Plasma protein binding by monosodium urate crystals. Analysis by two-dimensional gel electrophoresis Arthritis Rheum 26 775 783 6305372 10.1002/art.1780260612 1:CAS:528: DyaL3sXksFWgtbY%3D (Pubitemid 13099998)
27. GB Naff PH Byers 1973 Complement as a mediator of inflammation in acute gouty arthritis. I. Studies on the reaction between human serum complement and sodium urate crystals J Lab Clin Med 81 747 760 4349137 1:CAS:528: DyaE3sXksFWgurg%3D
28. TR Fields SB Abramson G Weissmann AP Kaplan B Ghebrehiwet 1983 Activation of the alternative pathway of complement by monosodium urate crystals Clin Immunol Immunopathol 26 249 257 6872344 10.1016/0090-1229(83)90143-5 1:CAS:528:DyaL3sXht1eqtbk%3D (Pubitemid 13187379)
29. N Tramontini C Huber R Liu-Bryan RA Terkeltaub KS Kilgore 2004 Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis Arthritis Rheum 50 2633 2639 15334478 10.1002/art.20386 (Pubitemid 39062725)
30. R Liu-Bryan K Pritzker GS Firestein R Terkeltaub 2005 TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation J Immunol 174 5016 5023 15814732 1:CAS:528:DC%2BD2MXivFKhsr0%3D (Pubitemid 40514462)
31. R Liu-Bryan P Scott A Sydlaske DM Rose R Terkeltaub 2005 Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation Arthritis Rheum 52 2936 2946 16142712 10.1002/art.21238 1:CAS:528:DC%2BD2MXhtFeltrbP (Pubitemid 41372129)
32. P Scott H Ma S Viriyakosol R Terkeltaub R Liu-Bryan 2006 Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals J Immunol 177 6370 6378 17056568 1:CAS:528:DC%2BD28XhtFSns7jL (Pubitemid 44642121)
33. CJ Chen, et al. 2006 MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals J Clin Invest 116 2262 2271 16886064 10.1172/JCI28075 1:CAS:528:DC%2BD28XnvF2mtL8%3D (Pubitemid 44162336)
34. G Ng, et al. 2008 Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells Immunity 29 807 818 18993083 10.1016/j.immuni.2008.09.013 1:CAS:528:DC%2BD1cXhsVaqsL7L This report suggests lipid sorting may be a mechanism for MSU-mediated activation.
35. F Martinon V Petrilli A Mayor A Tardivel J Tschopp 2006 Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 237 241 16407889 10.1038/nature04516 1:CAS:528:DC%2BD28XitFGitLg%3D (Pubitemid 43372104)
36. HM Hoffman, et al. 2010 Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice Arthritis Rheum 62 2170 2179 20506351 1:CAS:528:DC%2BC3cXht1aqsL3L This article presents structural insight into how NLRP3 may handle MSU-initiated activation.
37. SC Eisenbarth OR Colegio W O'Connor FS Sutterwala RA Flavell 2008 Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants Nature 453 1122 1126 18496530 10.1038/nature06939 1:CAS:528:DC%2BD1cXntlGjtLg%3D (Pubitemid 351871731)
38. M Kool, et al. 2008 Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells J Exp Med 205 869 882 18362170 10.1084/jem.20071087 1:CAS:528:DC%2BD1cXkvVyrsrc%3D (Pubitemid 351549884)
39. M Kool, et al. 2008 Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome J Immunol 181 3755 3759 18768827 1:CAS:528:DC%2BD1cXhtVKntLzK
40. V Hornung, et al. 2008 Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization Nat Immunol 9 847 856 18604214 10.1038/ni.1631 1:CAS:528:DC%2BD1cXoslCmurs%3D This article discusses a potential pathway for MSU-mediated IL-1β production.
41. C De Duve R Wattiaux 1966 Functions of lysosomes Annu Rev Physiol 28 435 492 5322983 10.1146/annurev.ph.28.030166.002251
42. NS Mandel 1976 The structural basis of crystal-induced membranolysis Arthritis Rheum 19 Suppl 3 439 445 181020 10.1002/1529-0131(197605/06)19: 3+<439::AID-ART1780190719>3.0.CO;2-L 1:CAS:528:DyaE28XkslGqsLg%3D
43. CJ Chen H Kono D Golenbock G Reed S Akira KL Rock 2007 Identification of a key pathway required for the sterile inflammatory response triggered by dying cells Nat Med 13 851 856 17572686 10.1038/nm1603 1:CAS:528:DC%2BD2sXnsFWmtrk%3D (Pubitemid 47038190)
44. DI Feig DH Kang RJ Johnson 2008 Uric acid and cardiovascular risk N Engl J Med 359 1811 1821 18946066 10.1056/NEJMra0800885 1:CAS:528:DC%2BD1cXht12nu7bI